Full name
SCAN LAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.23.Z - Dental practice
86.90.D - Healthcare
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 5,3 | 5,5 | 5,6 | 2,2 |
EBITDA | 6,7 | 9,3 | 69 | 644,9 |
Short time liabilities | 5,6 | 11 | 2 | -82 |
Equity capital | -2,2 | 2,5 | 7 | 182,2 |
Operating profit (EBIT) | 5,6 | 6,2 | 6,6 | 5,9 |
Assets | 9,4 | 13,5 | 20 | 48,5 |
Net profit (loss) | 5,3 | 4,7 | 4,5 | -3,3 |
Cash | 0,9 | 1 | 1,3 | 27,8 |
Liabilities and provisions for liabilities | 11,6 | 11 | 13 | 18,4 |
Net income from sale | 15,8 | 23,1 | 28,7 | 23,8 |
Working assets | 4,4 | 6,3 | 7,1 | 13,6 |
Depreciation | 1,1 | 3,1 | 62,5 | 1947,5 |
% | % | % | p.p. | |
Profitability of capital | -238,8 | 188,6 | 64,7 | -123,9 |
Equity capital to total assets | -23,5 | 18,4 | 35 | 16,6 |
Gross profit margin | 33,7 | 23,8 | 19,7 | -4,1 |
EBITDA Margin | 42,5 | 40,1 | 240,9 | 200,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 128 | 173 | 25 | -148 |
Current financial liquidity indicator | 0.7289589047431946 | 0.5709314346313477 | 3.611565589904785 | 3 |
Net dept to EBITDA | 1.4033018350601196 | 0.8043136596679688 | 0.1459103524684906 | -0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane